Results of the simplified tender offer
Valence, October 13, 2025, 8:30 a.m. CEST - Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI,
eligible for PEA-PME), the French leader in surgical technologies for lower limb orthopedics.


On 10 October 2025, the French Autorité des Marchés Financiers (AMF) announced the results of the
simplified tender offer initiated by Zydus MedTech (France) SAS on Amplitude Surgical SA shares,
following the closing of the offer on 9 October 2025. At the end of the offer, Zydus MedTech (France)
SAS and the companies it controls hold 47,097,741 shares, representing 98.08% of the capital and voting
rights of Amplitude Surgical SA.

Consequently, Zydus MedTech (France) SAS has filed a request with the AMF to implement a squeeze-
out procedure in order to obtain the transfer of the Amplitude Surgical SA shares not tendered to the
offer. The AMF will publish the timetable for the squeeze-out.

To the extent the squeeze-out would be effective before 31 October 2025, and in accordance with
applicable regulations, Amplitude Surgical SA will not communicate on its annual results, which were
scheduled to be announced on 22 October 2025.

The trading of Amplitude Surgical SA’s shares has been suspended by Euronext Paris since 10 October
2025 until the squeeze-out is implemented.


About Amplitude Surgical
Founded in 1997 in Valence, Amplitude Surgical is a leading French player in the global market for surgical
technologies for lower limb orthopedics. Amplitude Surgical develops and markets high-end products for
orthopedic surgery covering the main pathologies affecting the hip and knee. Amplitude Surgical develops, in close
collaboration with surgeons, a number of high value-added innovations to best meet the needs of patients,
surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is expanding internationally
through its subsidiaries and a network of exclusive agents and distributors in more than 30 countries. As of June
30, 2025, Amplitude Surgical employed 429 people and generated revenue of nearly €111 million.



Contact
Amplitude Surgical NewCap NewCap
Chief Financial Officer Investor Relations Media Relations
Dimitri Borchtch Thomas Grojean Nicolas Merigeau
finances@amplitude-surgical.com amplitude@newcap.eu amplitude@newcap.eu
+33 (0)4 75 41 87 41 +33 (0)1 44 71 94 94 +33 (0)1 44 71 94 98




1